Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukari Tsubata

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Respiratory Investigation|January 2, 2021
Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolismTakamasa Hotta, Yukari Tsubata, Kosuke Hamai, et al.
Anticancer Research|July 31, 2012
Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.
Frontiers in Oncology|April 18, 2022
A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled TrialCarolyn J Presley, Mostafa R Mohamed, Eva Culakova, et al.
The Journal of Medical Investigation : JMI|November 11, 2021
Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancerKazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, et al.
Geriatrics & Gerontology International|November 21, 2019
Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancerYukari Tsubata, Yohei Shiratsuki, Takae Okuno, et al.
Pharmacogenomics|April 3, 2012
Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancerAkinobu Hamada, Ji-Ichiro Sasaki, Sho Saeki, et al.
Anticancer Research|June 13, 2014
Immunohistochemical comparison of biomarker expression in biopsy and surgical specimens of non-small cell lung cancerTamio Okimoto, Yukari Tsubata, Akihisa Sutani, et al.
Respiratory Investigation|November 6, 2021
Results of 10-year mobile low-dose computed tomography screenings for lung cancer in Shimane, JapanMegumi Hamaguchi, Yukari Tsubata, Akari Tanino, et al.
Respiratory Investigation|October 4, 2024
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance statusKazuhisa Nakashima, Hiroaki Kodama, Haruyasu Murakami, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 7, 2013
Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumoniaFumi Karino, Kiyotaka Miura, Hiroshi Fuchita, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Respiratory Investigation|January 2, 2021
Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolismTakamasa Hotta, Yukari Tsubata, Kosuke Hamai, et al.
Anticancer Research|July 31, 2012
Tumor angiogenesis in 75 cases of pleomorphic carcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.
Frontiers in Oncology|April 18, 2022
A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled TrialCarolyn J Presley, Mostafa R Mohamed, Eva Culakova, et al.
The Journal of Medical Investigation : JMI|November 11, 2021
Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancerKazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, et al.
Geriatrics & Gerontology International|November 21, 2019
Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancerYukari Tsubata, Yohei Shiratsuki, Takae Okuno, et al.
Pharmacogenomics|April 3, 2012
Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancerAkinobu Hamada, Ji-Ichiro Sasaki, Sho Saeki, et al.
Anticancer Research|June 13, 2014
Immunohistochemical comparison of biomarker expression in biopsy and surgical specimens of non-small cell lung cancerTamio Okimoto, Yukari Tsubata, Akihisa Sutani, et al.
Respiratory Investigation|November 6, 2021
Results of 10-year mobile low-dose computed tomography screenings for lung cancer in Shimane, JapanMegumi Hamaguchi, Yukari Tsubata, Akari Tanino, et al.
Respiratory Investigation|October 4, 2024
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance statusKazuhisa Nakashima, Hiroaki Kodama, Haruyasu Murakami, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 7, 2013
Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumoniaFumi Karino, Kiyotaka Miura, Hiroshi Fuchita, et al.
Pageof 13